Detalles de la búsqueda
1.
Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell-depleted hematopoietic cell transplantation in pediatric and young adult patients.
Cytotherapy;
26(4): 351-359, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38349310
2.
Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy.
Blood;
138(7): 531-543, 2021 08 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33851211
3.
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia.
N Engl J Med;
378(5): 449-459, 2018 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29385376
4.
CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma.
Blood;
134(7): 626-635, 2019 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31262783
5.
Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL.
Blood;
134(26): 2361-2368, 2019 12 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31650176
6.
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.
Biol Blood Marrow Transplant;
25(4): 625-638, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30592986
7.
Donor-specific antibody desensitization with daratumumab prior to haematopoietic cell transplant for sickle cell disease: A case report.
Br J Haematol;
204(4): 1540-1544, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38212144
8.
Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutations.
J Allergy Clin Immunol;
152(3): 815-817, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37367708
9.
Building a CAR Garage: Preparing for the Delivery of Commercial CAR T Cell Products at Memorial Sloan Kettering Cancer Center.
Biol Blood Marrow Transplant;
24(6): 1135-1141, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29499327
10.
Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemia.
Blood;
138(21): 2138-2142, 2021 11 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34499715
11.
Successful reduced-intensity conditioning hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria with aplastic anemia in two children.
Pediatr Blood Cancer;
65(8): e27218, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29722478
12.
Enhancing antitumor efficacy of chimeric antigen receptor T cells through constitutive CD40L expression.
Mol Ther;
23(4): 769-78, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25582824
13.
Chimeric antigen receptors and bispecific antibodies to retarget T cells in pediatric oncology.
Pediatr Blood Cancer;
62(8): 1326-36, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25832831
14.
A robust quality infrastructure is key to safe and effective delivery of immune effector cells: how FACT-finding can help.
Blood Adv;
8(4): 1053-1061, 2024 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37467016
15.
T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML.
Bone Marrow Transplant;
59(1): 23-33, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37773270
16.
INSPIRED Symposium Part 1: Clinical Variables Associated with Improved Outcomes for Children and Young Adults treated with Chimeric Antigen Receptor T cells for B cell Acute Lymphoblastic Leukemia.
Transplant Cell Ther;
29(10): 598-607, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37481241
17.
Excellent leukemia control after second hematopoietic cell transplants with unrelated cord blood grafts for post-transplant relapse in pediatric patients.
Front Oncol;
13: 1221782, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37649924
18.
Validation of a High-Sensitivity Assay for Detection of Chimeric Antigen Receptor T-Cell Vectors Using Low-Partition Digital PCR Technology.
J Mol Diagn;
25(9): 634-645, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37330049
19.
Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation.
Blood Adv;
7(18): 5225-5233, 2023 09 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37379285
20.
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns.
EClinicalMedicine;
65: 102268, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37954907